Adrenergic drugs modify the level of noradrenaline in the insular cortex and alter extinction of conditioned taste aversion in rats

Behavioural Brain Research

Volumn 178, Issue 1, 2007, Pages 39-46

  Fresquet, Nadine ^a   Angst, Marie Josée ^b   Schleef, Carmen ^c   Gobaille, Serge ^c   Sandner, Guy ^b  

^a CNRS   (France)

^b INSERM   (France)

^c Centre de Neurochimie   (France)

Author keywords

2 Receptors; Alertness; Animal model of schizophrenia; Arousal; Attention; Awareness; Conditioned taste aversion; Drinking; Insular cortex; Learning; Memory; Microdialysis; Noradrenaline

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; GUANFACINE; IDAZOXAN; NORADRENALIN; SUCROSE;

ALERTNESS; ANIMAL EXPERIMENT; AROUSAL; ARTICLE; ATTENTION; AWARENESS; BRAIN; CANNULA; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRINKING; GLUCOSE BLOOD LEVEL; INSULA; LEARNING; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY CORTEX; SENSORY MEMORY; TASTE; TASTE AVERSION;

ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BLOOD GLUCOSE; CEREBRAL CORTEX; CONDITIONING, CLASSICAL; DRINKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; GUANFACINE; IDAZOXAN; MALE; MICRODIALYSIS; NOREPINEPHRINE; RATS; RATS, LONG-EVANS; RECEPTORS, ADRENERGIC, ALPHA-2; TASTE;

EID: 33846920863     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.11.047     Document Type: Article

References (56)

1. Archer T., Mohammed A.K., and Jarbe T.U. Latent inhibition following systemic DSP4: effects due to presence and absence of contextual cues in taste-aversion learning. Behav Neural Biol 38 (1983) 287-306
2. Arnsten A.F. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 31 (2006) 2376-2383
3. Arnsten A.F., Cai J.X., and Goldman-Rakic P.S. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypnotic side effects: evidence for alpha-2 receptor subtypes. J Neurosci 8 (1988) 4287-4298
4. Arnsten A.F., and Dudley A.G. Methylphenidate improves prefrontal cortical cognitive function through alpha2-adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Res 1 (2005) 2
5. Aston-Jones G. Brain structures and receptors involved in alertness. Sleep Med. Suppl. 1 (2005) S3-S7
6. Aston-Jones G., and Cohen J.D. An integrative theory of locus coeruleus-norepinephrine function: adaptative gain and optimal performance. Annu Rev Neurosci 28 (2005) 403-450
7. Berridge C.W., and Abercrombie E.D. Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis. Neuroscience 93 (1999) 1263-1270
8. Bevoets K., and Millan M.J. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A-as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord. J Pharmacol Exp Ther 269 (1994) 110-120
9. Birnbaum S.G., Podell D.M., and Arnsten A.F.T. Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats. Pharmacol Biochem Behav 67 (2000) 397-403
10. Coull J.T. Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs Aging 5 (1994) 116-126
11. Davies M.F., Tsui J., Flannery J.A., Li X., DeLorey T.M., and Hoffman B.B. Activation of alpha2 adrenergic receptors suppresses fear conditioning: expression of c-Fos and phosphorylated CREB in mouse amygdala. Neuropsychopharmacology 29 (2004) 229-239
12. Devedjian J.C., Pujol A., Cayla C., George M., Casellas A., Paris H., et al. Transgenic mice overexpressing alpha2A-adrenoreceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 43 (2000) 899-906
13. Devoto P., Flore G., Pira L., Longu G., and Gessa G.L. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 487 (2004) 105-111
14. Devoto P., Flore G., Saba P., Fa M., and Gessa G.L. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J Neurochem 92 (2005) 368-374
15. Dunn L.T., and Everitt B.J. The effects of lesions to noradrenergic projections from the locus coeruleus and lateral tegmental cell groups on conditioned taste aversion in the rat. Behav Neurosci 101 (1987) 409-422
16. 3H]rauwolscine? A comparison of nine tissues and cell lines. J Pharmacol Exp Ther 273 (1995) 1287-1294
17. Foote S.L., Berridge C.W., Adams L.M., and Pineda J.A. Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Prog Brain Res 88 (1991) 421-532
18. Fouquet N., Oberling P., and Sandner G. Differential effect of free intake versus oral perfusion of sucrose in conditioned taste aversion in rats. Physiol Behav 74 (2001) 465-474
19. Franowicz J.S., Kessler L.E., Borja C.M., Kobilka B.K., Limbird L.E., and Arnsten A.F. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J Neurosci 22 (2002) 8771-8777
20. Fresquet N., Yamamoto J., and Sandner G. Frontal lesions do not alter the differential extinction of taste aversion conditioning in rats, when using two methods of sucrose delivery. Behav Brain Res 141 (2003) 25-34
21. Fresquet N., Angst M.J., and Sandner G. Insular cortex lesions differentially alter extinction of conditioned taste aversion in rats, when using two methods of sucrose delivery. Behav Brain Res 153 (2004) 357-365
22. Giza B.K., and Scott T.R. Blood glucose affects perceived sweetness intensity in rats. Physiol Behav 41 (1987) 459-464
23. Haapalinna A., MacDonald E., Viitamaa T., Salonen J.S., Sirviö J., and Virtanen R. Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats. Naunyn-Scmiedeberg's Arch Pharmacol 359 (1999) 194-203
24. Haggard P., Martin F., Taylor-Clarke M., Jeannerod M., and Franck M. Awareness of action in schizophrenia. Neuroreport 14 (2003) 1081-1085
25. Intengan H.D., and Smyth D.D. Alpha-2A/D adrenoceptor subtype stimulation by guanfacine increases osmolar clearance. J Pharmacol Exp Ther 281 (1997) 48-53
26. Franck N., Farrer C., Georgieff N., Marie-Cardine M., Dalery J., d'Amato T., et al. Defective recognition of one's own actions in patients with schizophrenia. Am J Psychiatry 158 (2001) 454-459
27. 2-adrenoceptor sites in homogenates of rat brain. Br J Pharmacol 75 (1982) 401-408
28. Kawahara H., Kawahara Y., and Westerink B.H. The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis. Eur J Pharmacol 418 (2001) 177-186
29. 2-adrenoreceptors. Eur J Pharmacol 167 (1989) 95-104
30. Lena I., Parrot S., Deschaux O., Muffat-Joly S., Sauvinet V., Renaud B., et al. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep-wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J Neurosci Res 81 (2005) 891-899
31. McAllister K.H. The alpha 2 adrenoceptor antagonists RX 821002 and yohimbine delay-dependently impair choice accuracy in a delayed non-matching-to-position task in rats. Psychopharmacology (Berl.) 155 (2001) 379-388
32. Marrs W., Kuperman J., Avedian T., Roth R.H., and Jentsch J.D. Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats. Neuropsychopharmacology 30 (2005) 1500-1510
33. 2-adrenoceptor subtype located in rat locus coeruleus that modulates cortical noradrenaline release in vivo. Eur J Pharmacol 379 (1999) 53-57
34. Nakamura S., Ago Y., Itoh S., Koyama Y., Baba A., and Matsuda T. Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex. Eur J Pharmacol 528 (2005) 95-98
35. Newman-Tancredi A., Nicolas J.P., Audinot V., Gavaudan S., Verriele L., Trouzard M., et al. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 358 (1998) 197-206
36. Parker L.A. Taste avoidance and taste aversion: evidence for two different processes. Learn Behav 31 (2003) 165-172
37. Pineda J., Ugedo L., and Garcia-Sevilla J.A. Stimulatory effects of clonidine, crazoline and rilmenidine on locus coeruleus noradrenergic neurons: possible involvement of imidazoline-preferring receptors. Naunyn Schmiedebergs Arch Parmacol 348 (1993) 134-140
38. 2 binding sites. Eur J Pharmacol 392 (2000) 41-49
39. Pudovkina O.L., and Westerink B.H. Functional role of alpha1-adrenoceptors in the locus coeruleus: a microdialysis study. Brain Res 1061 (2005) 50-56
40. Riba J., Rodriguez-Fornells A., Morte A., Munte T.F., and Barbanoj M.J. Noradrenergic stimulation enhances human action monitoring. J Neurosci 25 (2005) 4370-4374
41. Sandner G. Lower animal conditioning studies help in the understanding of human memory and its disorders: the merits of conditioned taste, odor, and flavor aversion research. Am J Physiol Regul Integr Comp Physiol 286 (2004) R251-R253
42. Sara S.J. Learning by neurons: role of attention, reinforcement and behaviour. CR Acad Sci III, Paris 321 (1998) 193-198
43. Sederholm F., and Sodersten P. Aversive behavior during intraoral intake in male rats. Physiol Behav 74 (2001) 153-168
44. Shockley D.C., Wade L.H., and Williams-Johnson M.M. Effects of alpha-2-adrenoceptor agonists on induced diuresis in rats. Life Sci 53 (1993) 251-259
45. Sirviö J., Riekkinen Jr. P., Vajanto I., Koivisto E., and Riekkinen P.J. The effects of guanfacine, alpha-2 agonist, on the performance of young and aged rats in spatial navigation task. Behav Neural Biol 56 (1991) 101-107
46. Swanson L.W., and Hartman B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol 163 (1975) 467-505
47. 3H] RX 821002. Synapse 55 (2005) 126-132
48. Unnerstall J.R., Kopajtic T.A., and Kuhar M.J. Distribution of alpha 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res 319 (1984) 69-101
49. Vankov A., Herve-Minvielle A., and Sara S. Response to novelty and its rapid habituation in locus coeruleus neurons of the freely exploring rat. Eur J Neurosci 7 (1995) 1180-1187
50. Von Bruchhausen F. Inhibitory action of guanfacine on glucose uptake by adipose tissue not related to its alpha 2-adrenergic stimulatory potency. Arzneimittelforschung 35 (1985) 1813-1815
51. Westbrook R.F., Duffield T.Q., Good A.J., Halligan S., Seth A.K., and Swinbourne A.L. Extinction of within-event learning is contextually controlled and subject to renewal. Q J Exp Psychol B 48 (1995) 357-375
52. Williams J.T., Henderson G., and North R.A. Characterization of alpha 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurons. Neuroscience 14 (1985) 95-101
53. Wortley K.E., Heal D.J., and Stanford S.C. Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors. Br J Pharmacol 128 (1999) 659-666
54. Yamada F., Inoue S., Saitoh T., Tanaka K., Satoh S., and Takamura Y. Glucoregulatory hormones in the immobilization stress-induced increase of plasma glucose in fasted and fed rats. Endocrinology 132 (1993) 2199-2205
55. Yamamoto J., Fresquet N., and Sandner G. Conditioned taste aversion using four different means to deliver sucrose to rats. Physiol Behav 75 (2002) 387-396
56. Yasoshima Y., and Yamamoto T. Short-term and long-term excitability changes of the insular cortical neurons after the acquisition of taste aversion learning in behaving rats. Neuroscience 84 (1998) 1-5